secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001104659-21-115077
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharmaceuticals presents at H.C. Wainwright 23rd Annual Global Investment Conference
--------------------------------------------------------------------------------

- Presentation scheduled for September 13–15, 2021; materials available on company website.
- No financial results, guidance, or material disclosures included in the filing.
- Routine investor conference presentation with no specific new information provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465921115077/0001104659-21-115077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465921115077/tm2127509d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-115077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer